The government is examining Pfizer’s request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) V K Paul said on Thursday. At a press conference, Paul said, “Yes we are engaged with Pfizer and they
Due to the unprecedented COVID-19 crisis in India, the global supply of COVAX has been badly hit, so much so that there are many parts of the world where one shot has been dispensed to health workers or frontline workers and the second shot has
Is the 3 rd wave gonna impact kids more? As, we have seen things spanning out from December 2019, the first wave impacted the elderly the most, followed by people aged 18 to 45 in the second wave. Looking at the trend as
~Maximum queries around Covid-care, Mental Health, Women’s Health, Pediatrics and Orthopaedics~ It has been over a year since COVID-19 proved to be a threat to mankind. It has been mercilessly challenging our healthcare system; doctors and frontline workers. The healthcare infrastructure in our country moved from
Company has kept manufacturing facilities open during Lockdown and stepped up production of essential medical devices Supply chain has been expanded 40% to support quicker deliveries and access healthcare facilities in remote parts of the country Ramped up stock of critical product codes required
Company has kept manufacturing facilities open during Lockdown and stepped up production of essential medical devices Supply chain has been expanded 40% to support quicker deliveries and access healthcare facilities in remote parts of the country Ramped up stock of critical product codes required
MGM Healthcare, a super-specialty hospital in the heart of Chennai city, today announced that it has successfully conducted an emergency endoscopic transnasal orbital surgery to treat a 68-year-old female COVID-infected patient who got seriously affected with Black fungus (Mucormycosis). The patient was being treated for COVID
Zydus, an innovation driven global pharma major and TLC, a specialty pharmaceutical company in Taiwan, today announced the signing of a license supply and commercialization agreement to commercialize AmphoTLC™ (Amphotericin B Liposome for Injection 50mg) in India. AmphoTLC™ is a critical drug to treat Mucormycosis
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high risk* of severe COVID-19 Roche India and Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced
Vaccination can mitigate COVID-19 infection for Long-Term Vaccination can mitigate COVID-19 for the long term and drive India towards being a Covid free Nation. We have become the world hub for vaccines and if we depend on the three vaccines, the estimate is that by
